XML 18 R7.htm IDEA: XBRL DOCUMENT v3.21.2
Consolidated Statement of Stockholders' Equity - USD ($)
shares in Millions, $ in Millions
Total
Common Stock [Member]
Capital in Excess of Par Value [Member]
Retained Earnings [Member]
Accumulated Other Comprehensive Loss [Member]
Noncontrolling Interests [Member]
Beginning balance at Dec. 31, 2019 $ 5,215.5 $ 188.1 $ 3,825.7 $ 1,901.3 $ (759.6) $ 60.0
Beginning balance (in shares) at Dec. 31, 2019   188.1        
Net earnings 355.4     346.3   9.1
Net purchase of subsidiary shares from noncontrolling interests (10.8)         (10.8)
Dividends paid to noncontrolling interests (18.9)         (18.9)
Net change in pension asset/liability, net of taxes 1.2       1.2  
Foreign currency translation (380.1)       (381.3) 1.2
Change in fair value of derivative instruments, net of taxes (91.4)       (91.4)  
Compensation expense related to stock option plan grants 3.4   3.4      
Common stock issued in: purchase transactions 73.1 $ 0.7 72.4      
Common stock issued in: purchase transactions (in shares)   0.7        
Stock option plans 17.9 $ 0.4 17.5      
Stock option plans (in shares)   0.4        
Employee stock purchase plan 6.0 $ 0.1 5.9      
Employee stock purchase plan (in shares)   0.1        
Deferred compensation and restricted stock (15.0) $ 0.3 (15.3)      
Deferred compensation and restricted (in shares)   0.3        
Cash dividends declared on common stock (86.2)     (86.2)    
Ending balance at Mar. 31, 2020 5,070.1 $ 189.6 3,909.6 2,161.4 (1,231.1) 40.6
Ending balance, (in shares) at Mar. 31, 2020   189.6        
Beginning balance at Dec. 31, 2019 5,215.5 $ 188.1 3,825.7 1,901.3 (759.6) 60.0
Beginning balance (in shares) at Dec. 31, 2019   188.1        
Net earnings 705.0          
Net change in pension asset/liability, net of taxes 1.6          
Change in fair value of derivative instruments, net of taxes (83.7)          
Compensation expense related to stock option plan grants 10.1          
Ending balance at Sep. 30, 2020 5,818.2 $ 192.3 4,132.5 2,317.3 (870.4) 46.5
Ending balance, (in shares) at Sep. 30, 2020   192.3        
Beginning balance at Mar. 31, 2020 5,070.1 $ 189.6 3,909.6 2,161.4 (1,231.1) 40.6
Beginning balance (in shares) at Mar. 31, 2020   189.6        
Net earnings 161.8     153.7   8.1
Net purchase of subsidiary shares from noncontrolling interests 4.3         4.3
Dividends paid to noncontrolling interests (6.3)         (6.3)
Foreign currency translation 249.9       250.7 (0.8)
Change in fair value of derivative instruments, net of taxes (1.8)       (1.8)  
Compensation expense related to stock option plan grants 3.3   3.3      
Common stock issued in: purchase transactions 110.9 $ 1.2 109.7      
Common stock issued in: purchase transactions (in shares)   1.2        
Stock option plans 21.9 $ 0.5 21.4      
Stock option plans (in shares)   0.5        
Employee stock purchase plan 12.4 $ 0.1 12.3      
Employee stock purchase plan (in shares)   0.1        
Deferred compensation and restricted stock (5.2) $ 0.1 (5.3)      
Deferred compensation and restricted (in shares)   0.1        
Cash dividends declared on common stock (86.8)     (86.8)    
Ending balance at Jun. 30, 2020 5,534.5 $ 191.5 4,051.0 2,228.3 (982.2) 45.9
Ending balance, (in shares) at Jun. 30, 2020   191.5        
Net earnings 187.8     176.6   11.2
Net purchase of subsidiary shares from noncontrolling interests (0.8)         (0.8)
Dividends paid to noncontrolling interests (10.3)         (10.3)
Net change in pension asset/liability, net of taxes 0.4       0.4  
Foreign currency translation 102.4       101.9 0.5
Change in fair value of derivative instruments, net of taxes 9.5       9.5  
Compensation expense related to stock option plan grants 3.4   3.4      
Common stock issued in: purchase transactions 39.0 $ 0.4 38.6      
Common stock issued in: purchase transactions (in shares)   0.4        
Stock option plans 17.2 $ 0.3 16.9      
Stock option plans (in shares)   0.3        
Employee stock purchase plan 8.1 $ 0.1 8.0      
Employee stock purchase plan (in shares)   0.1        
Deferred compensation and restricted stock 14.6   14.6      
Cash dividends declared on common stock (87.6)     (87.6)    
Ending balance at Sep. 30, 2020 5,818.2 $ 192.3 4,132.5 2,317.3 (870.4) 46.5
Ending balance, (in shares) at Sep. 30, 2020   192.3        
Beginning balance at Dec. 31, 2020 $ 6,232.7 $ 193.7 4,264.4 2,371.7 (643.6) 46.5
Beginning balance (in shares) at Dec. 31, 2020 193.7 193.7        
Net earnings $ 393.7     382.1   11.6
Dividends paid to noncontrolling interests (10.3)         (10.3)
Net change in pension asset/liability, net of taxes 1.0       1.0  
Foreign currency translation 58.6       58.0 0.6
Change in fair value of derivative instruments, net of taxes 56.8       56.8  
Compensation expense related to stock option plan grants 3.7   3.7      
Common stock issued in: purchase transactions 67.5 $ 0.6 66.9      
Common stock issued in: purchase transactions (in shares)   0.6        
Stock option plans 30.2 $ 0.6 29.6      
Stock option plans (in shares)   0.6        
Employee stock purchase plan 7.0 $ 0.1 6.9      
Employee stock purchase plan (in shares)   0.1        
Shares issued to benefit plans 71.4 $ 0.6 70.8      
Shares issued to benefit plans (in shares)   0.6        
Deferred compensation and restricted stock (37.9) $ 0.3 (38.2)      
Deferred compensation and restricted (in shares)   0.3        
Cash dividends declared on common stock (94.9)     (94.9)    
Ending balance at Mar. 31, 2021 6,779.5 $ 195.9 4,404.1 2,658.9 (527.8) 48.4
Ending balance, (in shares) at Mar. 31, 2021   195.9        
Beginning balance at Dec. 31, 2020 $ 6,232.7 $ 193.7 4,264.4 2,371.7 (643.6) 46.5
Beginning balance (in shares) at Dec. 31, 2020 193.7 193.7        
Net earnings $ 834.1          
Net change in pension asset/liability, net of taxes 1.7          
Change in fair value of derivative instruments, net of taxes 28.4          
Compensation expense related to stock option plan grants $ 12.9          
Stock option plans (in shares) 1.1          
Ending balance at Sep. 30, 2021 $ 8,470.1 $ 207.3 5,962.3 2,873.8 (623.2) 49.9
Ending balance, (in shares) at Sep. 30, 2021 207.3 207.3        
Beginning balance at Mar. 31, 2021 $ 6,779.5 $ 195.9 4,404.1 2,658.9 (527.8) 48.4
Beginning balance (in shares) at Mar. 31, 2021   195.9        
Net earnings 201.8     190.2   11.6
Net purchase of subsidiary shares from noncontrolling interests (11.0)         (11.0)
Dividends paid to noncontrolling interests (7.4)         (7.4)
Net change in pension asset/liability, net of taxes 0.1       0.1  
Foreign currency translation 30.1       30.4 (0.3)
Change in fair value of derivative instruments, net of taxes (33.2)       (33.2)  
Compensation expense related to stock option plan grants 4.5   4.5      
Common stock issued in: purchase transactions 13.0 $ 0.1 12.9      
Common stock issued in: purchase transactions (in shares)   0.1        
Stock option plans 15.7 $ 0.3 15.4      
Stock option plans (in shares)   0.3        
Employee stock purchase plan 10.5 $ 0.1 10.4      
Employee stock purchase plan (in shares)   0.1        
Deferred compensation and restricted stock 12.2 $ 0.1 12.1      
Deferred compensation and restricted (in shares)   0.1        
Stock issuance from public offering 1,437.9 $ 10.3 1,427.6      
Stock issuance from public offering (in shares)   10.3        
Other compensation expense 0.3   0.3      
Cash dividends declared on common stock (100.0)     (100.0)    
Ending balance at Jun. 30, 2021 8,354.0 $ 206.8 5,887.3 2,749.1 (530.5) 41.3
Ending balance, (in shares) at Jun. 30, 2021   206.8        
Net earnings 238.6     225.1   13.5
Net purchase of subsidiary shares from noncontrolling interests 5.0         5.0
Dividends paid to noncontrolling interests (10.2)         (10.2)
Net change in pension asset/liability, net of taxes 0.6       0.6  
Foreign currency translation (97.8)       (98.1) 0.3
Change in fair value of derivative instruments, net of taxes 4.8       4.8  
Compensation expense related to stock option plan grants 4.7   4.7      
Common stock issued in: purchase transactions 35.1 $ 0.2 34.9      
Common stock issued in: purchase transactions (in shares)   0.2        
Stock option plans 7.7 $ 0.2 7.5      
Stock option plans (in shares)   0.2        
Employee stock purchase plan 14.8 $ 0.1 14.7      
Employee stock purchase plan (in shares)   0.1        
Deferred compensation and restricted stock 13.2   13.2      
Cash dividends declared on common stock (100.4)     (100.4)    
Ending balance at Sep. 30, 2021 $ 8,470.1 $ 207.3 $ 5,962.3 $ 2,873.8 $ (623.2) $ 49.9
Ending balance, (in shares) at Sep. 30, 2021 207.3 207.3